Abstract
Covering: 2009 up to August 2023 Prenyltransferases (PTs) are involved in the primary and the secondary metabolism of plants, bacteria, and fungi, and they are key enzymes in the biosynthesis of many clinically relevant natural products (NPs). The continued biochemical and structural characterization of the soluble dimethylallyl tryptophan synthase (DMATS) PTs over the past two decades have revealed the significant promise that these enzymes hold as biocatalysts for the chemoenzymatic synthesis of novel drug leads. This is a comprehensive review of DMATSs describing the structure-function relationships that have shaped the mechanistic underpinnings of these enzymes, as well as the application of this knowledge to the engineering of DMATSs. We summarize the key findings and lessons learned from these studies over the past 14 years (2009-2023). In addition, we identify current gaps in our understanding of these fascinating enzymes.
Original language | English |
---|---|
Pages (from-to) | 113-147 |
Number of pages | 35 |
Journal | Natural Product Reports |
Volume | 41 |
Issue number | 1 |
DOIs | |
State | Published - Nov 6 2023 |
Bibliographical note
Publisher Copyright:© 2024 The Royal Society of Chemistry.
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry